Onassis Cardiac Surgery Center — Clinical Trial Site

19 Registered trials

7 Currently recruiting

Organisation

Onassis Cardiac Surgery Center

Location

Kallithea, Greece

Identifier

ORG-100045367

Address

Leoforos Andrea Siggrou 356, 176 74, Greece

Departments

Cardiac Pacing and Electrophysiology, 356
Cardiology
Cardiology Department
Cardiology Division
Department of Pediatric Cardiology and Adult Congenital Heart Disease
Dpt of Heart Failure and Transplantation
Hemodynamic Research and Interventional Cardiology
Hemodynamic Research and Interventional Cardiology Department
Hemodynamic Studies and Invasive Cardiology
Non Invasive Cardiology Department
Unit of Inherited and Rare Cardiovascular Diseases
Unit of Inherited and Rare Cardiovascular Diseases

Clinical trials at this site (19)

Search interface

A study to learn more about how safe finerenone is, when it is taken for a longer time with standard treatment, in children and young adults… Recruiting

2024-519830-22-00 Heart failure due to systemic left ventricular systolic 5 2026-04-27
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Trepostini… Recruiting

2025-521558-40-00 Pulmonary Hypertension Associated with Interstitial Lun 5 2026-02-12
A Long-term Follow-up Study of Sotatercept for PAH Treatment Recruiting

2023-509138-21-00 Pulmonary Arterial Hypertension (PAH) 5 2021-08-26
A study to learn more about how well finerenone works, how safe it is, and how it moves into, through, and out of the body compared to place… Recruiting

2024-519829-38-00 Heart failure due to systemic left ventricular systolic 5 2026-01-09
An Open-Label Extension Study for Participants with PAH Who Have Previously Participated in a Clinical Trial with PF-07868489 Recruiting

2025-521155-23-00 Pulmonary Arterial Hypertension 4 2025-12-19
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme… Recruiting

2023-508875-35-00 Heart condition 5 2025-09-01
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten (CK-3773274) in Adults With Hypertrophic Cardiomyo… Recruiting

2023-508963-58-00 Symptomatic hypertrophic cardiomyopathy (HCM) 4 2022-01-31
A clinical study of sotatercept in people with pulmonary arterial hypertension (MK-7962-038) Ended

2025-521970-33-00 Pulmonary Arterial Hypertension (PAH) 5 2025-12-19
A Study to Learn How the Study Medicine Called PF-07868489 is Tolerated and Acts in Healthy Adult People and People With Pulmonary Arterial … Ended

2024-514064-17-00 Pulmonary Arterial Hypertension 3 2025-05-23
An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arte… Ended

2023-506334-75-00 Pulmonary Arterial Hypertension 5 2024-07-12
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
An open-label extension (OLE) study to evaluate the long-term safety and efficacy of ralinepag in patients with pulmonary arterial hypertens… Ended

2023-509305-68-00 Pulmonary arterial hypertension (PAH) 5 2019-05-16
A study of aficamten (CK-3773274) in adults with symptomatic non-obstructive hypertrophic cardiomyopathy (ACACIA) Ended

2023-505797-15-00 SYMPTOMATIC NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY 5 2024-09-13
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the … Ended

2023-503614-80-00 Pulmonary Arterial Hypertension 5 2023-12-14
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial – Follow Up Long Term Extension (IMPAHCT-FUL) Ended

2023-508735-31-00 Pulmonary Arterial Hypertension (PAH) 5 2023-05-05
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial (IMPAHCT) or A Phase 2b/3, Randomized, Controlled, 24-week Dose Ranging and … Ended

2023-508734-34-00 Pulmonary Arterial Hypertension (PAH) 10 2022-06-30
A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension (PAH) Patients. Ended

2023-509139-16-00 Therapeutic confirmatory (phase III) 5 2022-05-13
A study evaluating the efficacy and safety of ralinepag in treatment of patients with pulmonary arterial hypertension. Ended

2023-509304-16-00 Pulmonary arterial hypertension (PAH) 5 2019-05-16
Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy Ended

2022-502316-36-00 Symptomatic Obstructive Hypertrophic Cardiomyopathy 11